Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms

Harumi Okuyama1, Peter H Langsjoen, Tomohito Hamazaki

  • 1Nagoya City University and Institute for Consumer Science and Human Life, Kinjo Gakuin University, 2-1723 Omori, Moriyama, Nagoya 463-8521, Japan.

Insights

Statins may paradoxically worsen atherosclerosis and heart failure by depleting essential compounds like coenzyme Q10 and vitamin K2. This challenges the conventional view, suggesting a need to reevaluate statin treatment guidelines.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Current understanding posits statins reduce atherosclerosis via cholesterol reduction.
  • Emerging evidence suggests potential adverse effects of statins on vascular and cardiac health.

Purpose of the Study:

  • To present an alternative perspective on statin mechanisms of action.
  • To explore how statins might contribute to coronary artery calcification and heart failure.

Main Methods:

  • Review of biochemical pathways affected by statins.
  • Analysis of statin's impact on coenzyme Q10, heme A, vitamin K2, and selenium metabolism.
  • Correlation of these biochemical effects with cardiovascular pathologies.

Main Results:

  • Statins may act as mitochondrial toxins, impairing ATP generation by depleting coenzyme Q10 and heme A.
  • Inhibition of vitamin K2 synthesis by statins may reduce matrix Gla-protein activation, promoting arterial calcification.
  • Impaired biosynthesis of selenium-containing proteins, like glutathione peroxidase, may contribute to heart failure.

Conclusions:

  • Statins might paradoxically aggravate atherosclerosis and heart failure.
  • The pervasive use of statins warrants critical reevaluation of current treatment guidelines.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Inflammation01:38

Inflammation

Overview
65.9K